Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Ashok NuthanakantiDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York City, NY, USA.ORCID http://orcid.org/0000-0003-0105-3430
Megan KornDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York City, NY, USA.ORCID http://orcid.org/0000-0002-9280-2013
Rose Levenson-PalmerDepartment of Microbiology, New York University Grossman School of Medicine, New York City, NY, USA.
Yue WuDepartment of Chemistry, University of Wisconsin-Madison, Madison, WI, USA.
Nandhini Rajesh BabuDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York City, NY, USA.ORCID http://orcid.org/0009-0008-7676-8805
Robert S BanhDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York City, NY, USA.ORCID http://orcid.org/0000-0003-1959-4622
Alexander SerganovDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York City, NY, USA. alexander.serganov@nyulangone.org.ORCID http://orcid.org/0000-0001-8328-9310
Funding
X-ray Scattering Technology CoreP30GM133893 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI Sean McSweeney · 2019 to 2026
$38.6M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI Nozomi Ando, J Christopher Fromme · 2018 to 2026
$34.2M
Prokaryotic RNA Metabolism - Resubmission - 1R01GM035769 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BELASCO, JOEL G · 1986 to 2021
$7.1M
Mechanisms of bacterial RNA degradationR35GM145359 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOEL G BELASCO · 2022 to 2026
$4.0M
Molecular Basis for mRNA Decay in Bacteria - summer supplementR01GM112940 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SERGANOV, ALEXANDER · 2015 to 2023
$3.2M
Elucidating The Adaptive Role Of Serine Codons During Pancreatic Tumorigenesis - Diversity SupplementR37CA289040 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Robert Singhung Banh · 2024 to 2026
$1.8M
A universal approach for determining three-dimensional RNA structuresR21GM151508 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SERGANOV, ALEXANDER · 2023 to 2024
$466k
Damon Runyon Cancer Research Foundation (Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation) DRG-50-22NCI NIH HHS R37 CA289040NIGMS NIH HHS P30 GM124165NIGMS NIH HHS P30 GM133893NIGMS NIH HHS R01 GM035769NIGMS NIH HHS R01 GM112940NIGMS NIH HHS R21 GM151508NIGMS NIH HHS R35 GM145359U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R37CA289040U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM037569U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R01GM112940U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R21GM151508U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) R35GM145359
6 · The paper itself
Abstract
Enigmatic dinucleoside tetraphosphates, known as 'alarmones' (Np
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.